O'Brien Emily C, Fosbol Emil L, Peng S Andrew, Alexander Karen P, Roe Matthew T, Peterson Eric D
Departments of Clinical Pharmacology and Outcomes Research Duke Clinical Research Institute, Durham, NC; and Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark.
Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):102-9. doi: 10.1161/CIRCOUTCOMES.113.000421. Epub 2013 Dec 10.
Prior studies have found that obese patients have paradoxically lower in-hospital mortality after non-ST-segment-elevation myocardial infarction than their normal-weight counterparts, yet whether these associations persist long term is unknown.
We linked detailed clinical data for patients with non-ST-segment-elevation myocardial infarction aged ≥65 years in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) Registry to Medicare claims data to obtain longitudinal outcomes. Using height and weight measured on admission, patients were categorized into 6 body mass index (BMI [kilograms per meter squared]) groups. Multivariable Cox proportional hazards models were used to estimate the association between BMI and (1) all-cause mortality, (2) all-cause readmission, (3) cardiovascular readmission, and (4) noncardiovascular readmission for 3 years after hospital discharge. Among older patients with non-ST-segment-elevation myocardial infarction (n=34,465), 36.3% were overweight and 27.7% were obese. Obese patients were younger and more likely to have hypertension, diabetes mellitus, and dyslipidemia than normal or underweight patients. Relative to normal-weight patients, long-term mortality was lower for patients classified as overweight (BMI, 25.0-29.9), obese class I (BMI, 30.0-34.9), and obese class II (BMI, 35.0-39.9), but not obese class III (BMI ≥40.0). In contrast, 3-year all-cause and cardiovascular readmission were similar across BMI categories. Relative to normal-weight patients, noncardiovascular readmissions were similar for obese class I but higher for obese class II and obese class III.
All-cause long-term mortality was generally lower for overweight and obese older patients after non-ST-segment-elevation myocardial infarction relative to those with normal weight. Longitudinal readmissions were similar or higher with increasing BMI.
既往研究发现,肥胖患者在非ST段抬高型心肌梗死后的院内死亡率反常地低于体重正常的患者,但这些关联是否长期存在尚不清楚。
我们将≥65岁非ST段抬高型心肌梗死患者的详细临床数据(来自“能否通过早期实施美国心脏病学会/美国心脏协会指南快速对不稳定型心绞痛患者进行危险分层以抑制不良结局”[CRUSADE]注册研究)与医疗保险理赔数据相链接,以获取纵向结局。根据入院时测量的身高和体重,将患者分为6个体重指数(BMI[千克/平方米])组。使用多变量Cox比例风险模型来估计BMI与以下方面的关联:(1)全因死亡率,(2)全因再入院率,(3)心血管疾病再入院率,以及(4)出院后3年的非心血管疾病再入院率。在年龄较大的非ST段抬高型心肌梗死患者(n = 34465)中,36.3%为超重,27.7%为肥胖。与体重正常或体重过轻的患者相比,肥胖患者更年轻,更有可能患有高血压、糖尿病和血脂异常。相对于体重正常的患者,分类为超重(BMI,25.0 - 29.9)、I类肥胖(BMI,30.0 - 34.9)和II类肥胖(BMI,35.0 - 39.9)的患者长期死亡率较低,但III类肥胖(BMI≥40.0)患者并非如此。相比之下,各BMI类别间3年全因和心血管疾病再入院率相似。相对于体重正常的患者,I类肥胖患者的非心血管疾病再入院率相似,但II类和III类肥胖患者的非心血管疾病再入院率更高。
与体重正常的患者相比,超重和肥胖的老年患者在非ST段抬高型心肌梗死后的全因长期死亡率普遍较低。随着BMI增加,纵向再入院率相似或更高。